Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe Obesity
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Objective: Nonalcoholic fatty liver disease can lead to hepatic inflammation/damage. Understanding the physiological mechanisms that contribute to excess hepatic lipid accumulation may help identify effective treatments. Design: We recruited 25 nondiabetic patients with severe obesity scheduled for bariatric surgery. To evaluate liver export of triglyceride fatty acids, we measured very-low-density lipoprotein (VLDL)–triglyceride secretion rates the day prior to surgery using an infusion of autologous [1-14C]triolein-labeled VLDL particles. Ketone body response to fasting and intrahepatic long-chain acylcarnitine concentrations were used as indices of hepatic fatty acid oxidation. We measured intraoperative hepatic uptake rates of plasma free fatty acids using a continuous infusion of [U-13C]palmitate, combined with a bolus dose of [9,10-3H]palmitate and carefully timed liver biopsies. Total intrahepatic lipids were measured in liver biopsy samples to determine fatty liver status. The hepatic concentrations and enrichment from [U-13C]palmitate in diacylglycerols, sphingolipids, and acyl-carnitines were measured using liquid chromatography/tandem mass spectrometry. Results: Among study participants with fatty liver disease, intrahepatic lipid was negatively correlated with VLDL-triglyceride secretion rates (r = −0.92, P = 0.01) but unrelated to hepatic free fatty acid uptake or indices of hepatic fatty acid oxidation. VLDL-triglyceride secretion rates were positively correlated with hepatic concentrations of saturated diacylglycerol (r = 0.46, P = 0.02) and sphingosine-1-phosphate (r = 0.44, P = 0.03). Conclusion: We conclude that in nondiabetic humans with severe obesity, excess intrahepatic lipid is associated with limited export of triglyceride in VLDL particles rather than increased uptake of systemic free fatty acids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A study by Votruba et al (90) that examine meal FA storage of females with obesity showed that meal FA is more efficient in visceral than in subcutaneous fat, except in those with large amounts of visceral fat; the efficiency of meal FA storage decreases as a function of visceral fat mass.”
From Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans (2025) · cites this paper as [90]
In the citing paper
“In females with obesity given a mixed meal providing 40% REE, proportional meal fat storage is likewise greater in upper body subcutaneous fat than lower body subcutaneous fat and much greater than in visceral fat (90).”
From Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans (2025) · cites this paper as [90]
In the citing paper
“The same is not true in abdominal and femoral fat (90).”
From Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans (2025) · cites this paper as [90]
In the citing paper
“In general, the proportion of meal fat stored in upper body depots is the same or greater than that stored in the lower body (Table 3) (22, 88, 90).”
From Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans (2025) · cites this paper as [90]
Citations
Cites
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Sphingosine-1-phosphate: an enigmatic signalling lipid
Spiegel, S., & Milstien, S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1103 · Cited by 2,075
Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Koliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032
Splanchnic lipolysis in human obesity
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933
Self-citationOverproduction of large VLDL particles is driven by increased liver fat content in man
Adiels, M., Taskinen, M.-R., Packard, C., Caslake, M. J., Soro-Paavonen, A., Westerbacka, J., Vehkavaara, S., Häkkinen, A., Olofsson, S.-O., Yki-Järvinen, H., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0125-z · Cited by 690
Sunny, N. E., Parks, E. J., Browning, J. D., & Burgess, S. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.004 · Cited by 672
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
Kumashiro, N., Erion, D. M., Zhang, D., Kahn, M., Beddow, S. A., Chu, X., Still, C. D., Gerhard, G. S., Han, X., Dziura, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113359108 · Cited by 585
Effect of bariatric surgery on nonalcoholic fatty liver disease: Systematic review and meta-analysis
Mummadi, R. R., Kasturi, K. S., Chennareddygari, S., & Sood, G. K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.012 · Cited by 511
Lewis, G. F., Uffelman, K. D., Szeto, L. W., Weller, B., & Steiner, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117633 · Cited by 502
Inositol trisphosphate and diacylglycerol as intracellular second messengers in liver
Williamson, J. R., Cooper, R. H., Joseph, S. K., & Thomas, A. P. (1985) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1985.248.3.c203 · Cited by 421
Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance
Choi, S. H., & Ginsberg, H. N. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.04.007 · Cited by 418
Westerbacka, J., Kolak, M., Kiviluoto, T., Arkkila, P., Sirén, J., Hamsten, A., Fisher, R. M., & Yki-Järvinen, H. (2007) · Diabetes · doi:10.2337/db07-0156 · Cited by 355
Jensen, M., Kanaley, J., Reed, J., & Sheedy, P. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.2.274 · Cited by 344
Self-citationPredictors of Nonalcoholic Steatohepatitis and Advanced Fibrosis in Morbidly Obese Patients
Ong, J. P., Elariny, H., Collantes, R., Younoszai, A., Chandhoke, V., Reines, H. D., Goodman, Z., & Younossi, Z. M. (2005) · Obesity Surgery · doi:10.1381/0960892053576820 · Cited by 322
Role of ceramides in nonalcoholic fatty liver disease
Pagadala, M., Kasumov, T., McCullough, A. J., Zein, N. N., & Kirwan, J. P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.04.005 · Cited by 303
Kotronen, A., Seppänen-Laakso, T., Westerbacka, J., Kiviluoto, T., Arola, J., Ruskeepää, A.-L., Orešič, M., & Yki-Järvinen, H. (2009) · Diabetes · doi:10.2337/db08-1074 · Cited by 245
Adiels, M., Westerbacka, J., Soro-Paavonen, A., Häkkinen, A. M., Vehkavaara, S., Caslake, M. J., Packard, C., Olofsson, S. O., Yki-Järvinen, H., Taskinen, M. R., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0790-1 · Cited by 198
Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168
Validation of a new method for determination of free fatty acid turnover
Miles, J. M., Ellman, M. G., McClean, K. L., & Jensen, M. D. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.3.e431 · Cited by 161
Self-citationGorden, D. L., Ivanova, P. T., Myers, D. S., McIntyre, J. O., VanSaun, M. N., Wright, J. K., Matrisian, L. M., & Brown, H. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022775 · Cited by 155
Free Fatty Acid Uptake in Humans With CD36 Deficiency
Hames, K. C., Vella, A., Kemp, B. J., & Jensen, M. D. (2014) · Diabetes · doi:10.2337/db14-0369 · Cited by 132
Self-citationGlycolipids and other lipid constituents of normal human liver
Kwiterovich, P. O., Sloan, H. R., & Fredrickson, D. S. (1970) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42968-2 · Cited by 132
Rapid measurement of plasma free fatty acid concentration and isotopic enrichment using LC/MS
Persson, X.-M. T., Błachnio-Zabielska, A. U., & Jensen, M. D. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m008011 · Cited by 121
Self-citationVLDL triglyceride kinetics in lean, overweight, and obese men and women
Mittendorfer, B., Yoshino, M., Patterson, B. W., & Klein, S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1500 · Cited by 108
Blachnio‐Zabielska, A. U., Persson, X. T., Koutsari, C., Zabielski, P., & Jensen, M. D. (2012) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.6216 · Cited by 102
Self-citationKanaley, J. A., Shadid, S., Sheehan, M. T., Guo, Z., & Jensen, M. D. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.180695 · Cited by 92
Self-citationScherer, M., Böttcher, A., Schmitz, G., & Liebisch, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.11.003 · Cited by 92
Gill, J. M. R., Brown, J. C., Bedford, D. K., Wright, D. M., Cooney, J., Hughes, D. A., Packard, C. J., & CASLAKE, M. J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.04.022 · Cited by 88
Lightle, S. A., Tosheva, R., Lee, A. S., Queen-Baker, J., Boyanovsky, B. B., Shedlofsky, S., & Nikolova‐Karakashian, M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.031 · Cited by 87
Heated hand vein blood is satisfactory for measurements during free fatty acid kinetic studies
Jensen, M. D., & Heiling, V. J. (1991) · Metabolism · doi:10.1016/0026-0495(91)90152-m · Cited by 77
Self-citationEffects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
Walsh, B. W., & Sacks, F. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116437 · Cited by 76
Effects of exercise on VLDL-triglyceride oxidation and turnover
Sondergaard, E., Rahbek, I., Sørensen, L. P., Christiansen, J. S., Gormsen, L. C., Jensen, M. D., & Nielsen, S. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00031.2011 · Cited by 61
Self-citationRigazio, S., Lehto, H., Tuunanen, H., Någren, K., Kankaanpää, M., Simi, C., Borra, R., Naum, A. S., Parkkola, R. K., Knuuti, J. M., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00744.2007 · Cited by 56
Basal and insulin-regulated free fatty acid and glucose metabolism in humans
Shadid, S., Kanaley, J. A., Sheehan, M. T., & Jensen, M. D. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00655.2006 · Cited by 55
Self-citationBrundin, T., Thörne, A., & Wahren, J. (1992) · Metabolism · doi:10.1016/0026-0495(92)90190-l · Cited by 51
Impaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease
Poulsen, M. K., Nellemann, B., Stødkilde-Jørgensen, H., Pedersen, S. B., Grønbæk, H., & Nielsen, S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3476 · Cited by 39
Thermogenesis after a mixed meal: role of leg and splanchnic tissues in men and women
Jensen, M. D., Johnson, C. M., Cryer, P. E., & Murray, M. J. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.3.e433 · Cited by 39
Self-citationBlachnio-Zabielska, A. U., Zabielski, P., & Jensen, M. D. (2013) · Journal of Lipid Research · doi:10.1194/jlr.d035006 · Cited by 36
Self-citationPerona, J. S., & RUIZGUTIERREZ, V. (2003) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00861-9 · Cited by 34
Sørensen, L. P., Gormsen, L. C., & Nielsen, S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00366.2009 · Cited by 30
Bush, N. C., Triay, J. M., Gathaiya, N. W., Hames, K. C., & Jensen, M. D. (2014) · Metabolism · doi:10.1016/j.metabol.2013.09.008 · Cited by 22
Self-citationAllister, E. M., Pal, S., Thomson, A. M., Helmerhorst, E., & Mamo, J. C. L. (2004) · Journal of Biomedical Science · doi:10.1007/bf02254364 · Cited by 5
Cited by
Metabolic-associated fatty liver disease and lipoprotein metabolism
Heeren, J., & Scheja, L. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101238 · Cited by 646
“This adaptation is, however, limited, as shown by studies indicating that VLDL secretion rates reach a plateau in mild to moderate steatosis and may even decrease upon progression to severe steatosis [52,83] and/or steatohepatitis [84,85].”
BackgroundMetabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Masoodi, M., Gastaldelli, A., Hyötyläinen, T., Arretxe, E., Alonso, C., Gaggini, M., Brosnan, J., Anstee, Q. M., Millet, O., Ortiz, P., et al. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00502-9 · Cited by 451
Azzu, V., Vacca, M., Virtue, S., Allison, M., & Vidal-Puig, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.054 · Cited by 369
Hepatic lipid droplet homeostasis and fatty liver disease
Seebacher, F., Zeigerer, A., Kory, N., & Krahmer, N. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.04.011 · Cited by 190
“Indeed, several findings in humans support this hypothesis: in patients with NASH the increase in VLDL secretion does not reach the extent of triglyceride synthesis (96) and in obese humans intrahepatic lipid was found to be negatively correlated with VLDL-triglyceride secretion rates (97).”
BackgroundLipid droplet contact sites in health and disease
Herker, E., Vieyres, G., Beller, M., Krahmer, N., & Bohnert, M. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.01.004 · Cited by 174
“In patients with non-alcoholic steatohepatitis (NASH), the increase in VLDL secretion does not reach the extent of TAG synthesis [93] and intrahepatic lipid levels are negatively correlated with VLDL-TAG secretion rates [94].”
Background
Metadata
- Authors
- Lytle, K. A., Bush, N. C., Triay, J. M., Kellogg, T. A., Kendrick, M. L., Swain, J. M., Gathaiya, N. W., Hames, K. C., & Jensen, M. D.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Jensen, Michael D
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2019-08-13
- Volume
- 104
- Issue
- 12
- Pages
- 6171-6181
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC6821207
- OpenAlex
- W2968560092
- Cited by
- 35
- References
- 44
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 7 · 2023: 3 · 2022: 7 · 2021: 7 · 2020: 4
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK40484, DK45343, DK50456)
- National Institutes of Health (UL1 RR24150, T32 DK07352)
- National Center for Advancing Translational Sciences (UL1 TR000135)
- American Diabetes Association (7-112-MN-36)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- non-alcoholic fatty liver disease, morbid obesity, hepatic lipid accumulation, VLDL triglyceride secretion, hepatic fatty acid oxidation, ketone bodies, long-chain acylcarnitines, diacylglycerol, sphingosine-1-phosphate, sphingolipids, hepatic lipolysis, bariatric surgery
- MeSH terms
- Adolescent, Adult, Fatty Acids, Fatty Acids, Nonesterified, Female, Humans, Lipoproteins, VLDL, Liver, Male, Middle Aged, Obesity, Morbid, Sphingolipids, Triglycerides, Bariatric Surgery, Lipid Metabolism, Young Adult, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.